Browse > Article

$PPAR_{\gamma}$ Ligand-binding Activity of Fragrin A Isolated from Mace (the Aril of Myristica fragrans Houtt.)  

Lee, Jae-Young (Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University)
Kim, Ba-Reum (Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University)
Oh, Hyun-In (Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University)
Shen, Lingai (Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University)
Kim, Naeung-Bae (Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University)
Hwang, Jae-Kwan (Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University)
Publication Information
Food Science and Biotechnology / v.17, no.6, 2008 , pp. 1146-1150 More about this Journal
Abstract
Peroxisome proliferator-activated receptor-gamma ($PPAR_{\gamma}$), a member of the nuclear receptor of ligand-activated transcription factors, plays a key role in lipid and glucose metabolism or adipocytes differentiation. A lignan compound was isolated from mace (the aril of Myristica fragrans Houtt.) as a $PPAR_{\gamma}$ ligand, which was identified as fragrin A or 2-(4-allyl-2,6-dimethoxyphenoxy)-1-(4-hydroxy-3-methoxyphenyl)-propane. To ascertain whether fragrin A has $PPAR_{\gamma}$ ligand-binding activity, it was performed that GAL-4/$PPAR_{\gamma}$ transactivation assay. $PPAR_{\gamma}$ ligand-binding activity of fragrin A increased 4.7, 6.6, and 7.3-fold at 3, 5, and $10{\mu}M$, respectively, when compared with a vehicle control. Fragrin A also enhanced adipocytes differentiation and increased the expression of $PPAR_{\gamma}$ target genes such as adipocytes fatty acid-binding protein (aP2), lipoprotein lipase (LPL), and phosphoenol pyruvate carboxykinase (PEPCK). Furthermore, it significantly increased the expression level of glucose transporter 4 (GLUT4). These results indicate that fragrin A can be developed as a $PPAR_{\gamma}$ agonist for the improvement of insulin resistance associated with type 2 diabetes.
Keywords
peroxisome proliferator-activated receptor-gamma ($PPAR_{\gamma}$); mace; Myristica fragrans Houtt. (nutmeg); fragrin A; type 2 diabetes;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
1 Braissant O, Wahli W. Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development. Endocrinology 139: 2748-2754 (1998)   DOI   ScienceOn
2 Tang WH, Maroo A. PPARgamma agonists: Safety issues in heart failure. Diabetes Obes. Metab. 9: 447-454 (2007)   DOI   ScienceOn
3 Hattori M, Hada S, Shu YZ, Kakiuchi N, Namba T. New acyclic bis-phenylpropanoids from the aril of Myristica fragrans. Chem. Pharm. Bull. 35: 668-674 (1987)   DOI
4 Wright HM, Clish CB, Mikami T, Hauser S, Yanagi K, Hiramatsu R, Serhan CN, Spiegelman BM. A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation. J. Biol. Chem. 275: 1873-1877 (2000)   DOI   ScienceOn
5 Berger J, Moller DE. The mechanisms of action of PPARs. Annu. Rev. Med. 53: 409-435 (2002)   DOI   ScienceOn
6 Baxa CA, Sha RS, Buelt MK, Smith AJ, Matarese V, Chinander LL, Boundy KL, Bernlohr DA. Human adipocyte lipid-binding protein: Purification of the protein and cloning of its complementary DNA. Biochemistry 28: 8683-8690 (1989)   DOI   ScienceOn
7 Kim SY, Park SM, Lee ST. Apolipoprotein C II is a novel substrate for matrix metalloproteinases. Biochem. Bioph. Res. Co. 339: 47-54 (2006)   DOI   ScienceOn
8 Farese RV, Sajan MP, Standaert ML. Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): Actions and defects in obesity and type II diabetes. Exp. Biol. Med. 230: 593-605 (2005)   DOI
9 Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414: 821-827 (2001)   DOI   ScienceOn
10 Kim GS, Lee GY, Nedumaran B, Park YY, Kim KT, Park SC, Lee YC, Kim JB, Choi HS. The orphan nucler receptor DAX-1 acts as a novel transcriptional corepressor of $PPAR_{\gamma}$. Biochem. Bioph. Res. Co. 370: 264-268 (2008)   DOI   ScienceOn
11 He TC, Chan TA, Vogelstein B, Kinzler KW. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99: 335-345 (1999)   DOI   ScienceOn
12 Rubenstrunk A, Hanf R, Hum DW, Fruchart JC, Staels B. Safety issues and prospects for future generations of PPAR modulators. Biochim. Biophys. Acta 1771: 1065-1081 (2007)   DOI   ScienceOn
13 Han KL, Jung MH, Sohn JH, Hwang JK. Ginsenoside 20(S)-protopanaxatriol (PPT) activates peroxisome proliferators-activated receptor ${\gamma}$ in 3T3-L1 adipocyte. Biol. Pham. Bull. 29: 110-113 (2006)   DOI   ScienceOn
14 Spiegelman BM. PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor. Diabetes 47: 507-514 (1998)   DOI   ScienceOn
15 Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-delta12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83: 803-812 (1995)   DOI   ScienceOn
16 Lee SY, Hwang JY, Kang MJ, Kim YM, Jung SH, Lee JH, Kim JI. Hypoglycemic effect of onion skin extract in animal models of diabetes mellitus. Food Sci. Biotechnol. 17: 130-134 (2008)   과학기술학회마을
17 Huang TH, Kota BP, Razmovski V, Roufoqalis BD. Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome. Basic Clin. Pharmacol. 96: 3-14 (2005)   DOI   ScienceOn
18 Kersten S, Desvergne B, Wahli W. R oles of PPARs in health and disease. Nature 405: 421-424 (2000)   DOI   ScienceOn
19 Graham DJ, Green L, Senior JR, Nourjah P. Troglitazone-induced liver failure: A case study. Am. J. Med. 114: 299-306 (2003)   DOI   ScienceOn
20 Cadoudal T, Fouque F, Benelli C, Forest C. Glyceroneogenesis and PEPCK-C: Pharmacologucal targets in type 2 diabetes. Med. Sci. 24: 407-414 (2008)